Betoptic Pilo is a drug owned by Alcon Laboratories Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jun 03, 2014. Details of Betoptic Pilo's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5635172 | Sustained release comfort formulation for glaucoma therapy |
Jun, 2014
(10 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Betoptic Pilo is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Betoptic Pilo's family patents as well as insights into ongoing legal events on those patents.
Betoptic Pilo's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Betoptic Pilo's generic launch date based on the expiry of its last outstanding patent is estimated to be Jun 03, 2014 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Betoptic Pilo Generics:
There are no approved generic versions for Betoptic Pilo as of now.
About Betoptic Pilo
Betoptic Pilo is a drug owned by Alcon Laboratories Inc. It is used for reducing intraocular pressure in humans. Betoptic Pilo uses Betaxolol Hydrochloride; Pilocarpine Hydrochloride as an active ingredient. Betoptic Pilo was launched by Alcon in 1997.
Approval Date:
Betoptic Pilo was approved by FDA for market use on 17 April, 1997.
Active Ingredient:
Betoptic Pilo uses Betaxolol Hydrochloride; Pilocarpine Hydrochloride as the active ingredient. Check out other Drugs and Companies using Betaxolol Hydrochloride; Pilocarpine Hydrochloride ingredient
Treatment:
Betoptic Pilo is used for reducing intraocular pressure in humans.
Dosage:
Betoptic Pilo is available in suspension/drops form for ophthalmic use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| EQ 0.25% BASE;1.75% | SUSPENSION/DROPS | Discontinued | OPHTHALMIC |